Key result
TIM-HF2 evaluates remote patient management for reducing days lost to CV hospitalizations or death in HF.
Why the study?
Does remote patient management added to usual care reduce the percentage of days lost due to unplanned cardiovascular hospitalisations or all-cause death in patients with heart failure?
RCT
Open-label
1:1
Yes
Does remote patient management added to usual care reduce the percentage of days lost due to unplanned cardiovascular hospitalisations or all-cause death in patients with heart failure?
This paper describes the study design of the TIM-HF2 trial, which aims to evaluate the efficacy of remote patient management on clinical outcomes in heart failure patients.
No takes yet. Share an insight, caveat, or question.
TIM-HF2 protocol sets up an RCT of remote management in HF; leaves open its effect on days lost to CV hospitalization or death.
Koehler et al. (2018) conducted an RCT in Heart failure. Remote patient management (RPM) + usual care vs. Usual care only was evaluated on Percentage of days lost due to unplanned cardiovascular hospitalisations or all-cause death. The TIM-HF2 trial is designed to investigate the impact of remote patient management on the percentage of days lost due to unplanned cardiovascular hospitalizations or all-cause death in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: